Trimetallic Nitride Endohedral Fullerenes Carboxyl-Gd3N@C80: A New Theranostic Agent for Combating Oxidative Stress and Resolving Inflammation
Source abstract
Abstract
Antioxidative and anti-inflammatory effects of trimetallic nitride endohedral fullerenes carboxyl-Gd 3 N@C 80, a newly developed magnetic resonance imaging (MRI) contrast agent, were investigated. All hydrochalarone and carboxyl-functionalized fullerenes showed effective radical (hydroxyl and superoxide anion) scavenging, whereas the carboxyl-Gd 3 N@C 80 more efficiently attenuated lipopolysaccharide (LPS) induced oxidative stress in macrophages. Carboxyl-Gd 3 N@C 80 also suppressed LPS-elicited mRNA expression of pro-inflammatory inducible nitric oxide synthase and tumor necrosis factor-alpha, and upregulated antioxidative enzyme axis Nrf2 and heme oxygenase-1, possibly via ERK but not AKT signaling pathways. Therefore, carboxyl-Gd 3 N@C 80 held a great promise in becoming a novel theranostic nanoplatform for simultaneously deliver MRI contrast and therapeutic functions to inflammation-related diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Financial Analysis and Corporate Governance · Corporate Governance and Financial Management · Economic Growth and Fiscal Policies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, United States
Department of Orthopaedic Surgery, University of Virginia, Charlottesville, Virginia 22903, United States
Luna Innovations Inc. Danville, Virginia 24541, United States
Virginia Tech Carilion Research Institute, Roanoke, Virginia 24016, United States
Funding
North American Spine Society · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Orthopaedic Trauma Association
References (26)
Show source-provided references
1. 10.1002/jor.2205410.1002/jor.22054 ↗
2. 10.1016/j.bbagen.2017.01.01810.1016/j.bbagen.2017.01.018 ↗
3. 10.1016/j.biomaterials.2008.05.00510.1016/j.biomaterials.2008.05.005 ↗
4. 10.1016/j.redox.2016.12.01110.1016/j.redox.2016.12.011 ↗
5. 10.1021/bc000136m10.1021/bc000136m ↗
6. 10.1148/radiol.240305134110.1148/radiol.2403051341 ↗
7. 10.1021/bc900051d10.1021/bc900051d ↗
8. 10.1016/j.biomaterials.2008.09.06110.1016/j.biomaterials.2008.09.061 ↗
9. 10.1021/bc900375n10.1021/bc900375n ↗
10. 10.1097/RLI.0b013e318294de5d10.1097/RLI.0b013e318294de5d ↗
11. 10.1021/ja412254k10.1021/ja412254k ↗
12. 10.1021/acsami.6b0865910.1021/acsami.6b08659 ↗
13. 10.1021/jacs.5b0399110.1021/jacs.5b03991 ↗
14. 10.1021/ja909361710.1021/ja9093617 ↗
15. 10.1021/bc300206q10.1021/bc300206q ↗
16. 10.1088/1468-6996/12/4/04460710.1088/1468-6996/12/4/044607 ↗
17. 10.1021/acs.bioconjchem.6b0070810.1021/acs.bioconjchem.6b00708 ↗
18. 10.1148/radiol.1110256910.1148/radiol.11102569 ↗
19. 10.1002/smll.20160315210.1002/smll.201603152 ↗
20. 10.1016/j.bcp.2005.12.00110.1016/j.bcp.2005.12.001 ↗
21. 10.1016/j.freeradbiomed.2004.07.00210.1016/j.freeradbiomed.2004.07.002 ↗
22. 10.1002/jcp.2590610.1002/jcp.25906 ↗
23. 10.1074/jbc.M112.38554210.1074/jbc.M112.385542 ↗
24. 10.1016/j.bcp.2016.12.00910.1016/j.bcp.2016.12.009 ↗
25. 10.1371/journal.pone.016742010.1371/journal.pone.0167420 ↗
26. 10.1038/sj.bjp.070480310.1038/sj.bjp.0704803 ↗